Skip to main content
Top
Published in: BMC Health Services Research 1/2015

Open Access 01-12-2015 | Research article

Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process

Authors: Yinghui Xu, Barcey T Levy, Jeanette M Daly, George R Bergus, Jeffrey C Dunkelberg

Published in: BMC Health Services Research | Issue 1/2015

Login to get access

Abstract

Background

In average-risk individuals aged 50 to 75 years, there is no difference in life-years gained when comparing colonoscopy every 10 years vs. annual fecal immunochemical testing (FIT) for colorectal cancer screening. Little is known about the preferences of patients when they have experienced both tests.

Methods

The study was conducted with 954 patients from the University of Iowa Hospital and Clinics during 2010 to 2011. Patients scheduled for a colonoscopy were asked to complete a FIT before the colonoscopy preparation. Following both tests, patients completed a questionnaire which was based on an analytic hierarchy process (AHP) decision-making model.

Results

In the AHP analysis, the test accuracy was given the highest priority (0.457), followed by complications (0.321), and test preparation (0.223). Patients preferred colonoscopy (0.599) compared with FIT (0.401) when considering accuracy; preferred FIT (0.589) compared with colonoscopy (0.411) when considering avoiding complications; and preferred FIT (0.650) compared with colonoscopy (0.350) when considering test preparation. The overall aggregated priorities were 0.517 for FIT, and 0.483 for colonoscopy, indicating patients slightly preferred FIT over colonoscopy. Patients’ preferences were significantly different before and after provision of detailed information on test features (p < 0.0001).

Conclusions

AHP analysis showed that patients slightly preferred FIT over colonoscopy. The information provided to patients strongly affected patient preference. Patients’ test preferences should be considered when ordering a colorectal cancer screening test.
Literature
1.
go back to reference American Cancer Society. Cancer facts & figures 2013. Atlanta: American Cancer Society; 2013. American Cancer Society. Cancer facts & figures 2013. Atlanta: American Cancer Society; 2013.
2.
go back to reference Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544–73.CrossRefPubMedPubMedCentral Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544–73.CrossRefPubMedPubMedCentral
3.
go back to reference Qaseem A, Denberg TD, Hopkins Jr RH, Humphrey LL, Levine J, Sweet DE, et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med. 2012;156(5):378–86.CrossRefPubMed Qaseem A, Denberg TD, Hopkins Jr RH, Humphrey LL, Levine J, Sweet DE, et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med. 2012;156(5):378–86.CrossRefPubMed
4.
go back to reference Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC, Centers for Disease Control and Prevention (CDC). Colorectal cancer screening - United States, 2002, 2004, 2006, and 2008. MMWR Surveill Summ. 2011;60 Suppl:42–6. Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC, Centers for Disease Control and Prevention (CDC). Colorectal cancer screening - United States, 2002, 2004, 2006, and 2008. MMWR Surveill Summ. 2011;60 Suppl:42–6.
5.
go back to reference Hawley ST, McQueen A, Bartholomew LK, Greisinger AJ, Coan SP, Myers R, et al. Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice. Cancer. 2012;118(10):2726–34.CrossRefPubMed Hawley ST, McQueen A, Bartholomew LK, Greisinger AJ, Coan SP, Myers R, et al. Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice. Cancer. 2012;118(10):2726–34.CrossRefPubMed
6.
go back to reference Wolf RL, Basch CE, Brouse CH, Shmukler C, Shea S. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health. 2006;96(5):809–11.CrossRefPubMedPubMedCentral Wolf RL, Basch CE, Brouse CH, Shmukler C, Shea S. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health. 2006;96(5):809–11.CrossRefPubMedPubMedCentral
7.
go back to reference Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15(2):389–94.CrossRefPubMed Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2006;15(2):389–94.CrossRefPubMed
8.
go back to reference Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99(19):1462–70.CrossRefPubMed Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007;99(19):1462–70.CrossRefPubMed
9.
go back to reference van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135(1):82–90.CrossRefPubMed van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135(1):82–90.CrossRefPubMed
11.
go back to reference Allison JE. FIT: a valuable but underutilized screening test for colorectal cancer-it’s time for a change. Am J Gastroenterol. 2010;105(9):2026–8.CrossRefPubMed Allison JE. FIT: a valuable but underutilized screening test for colorectal cancer-it’s time for a change. Am J Gastroenterol. 2010;105(9):2026–8.CrossRefPubMed
12.
go back to reference Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):659–69.CrossRefPubMedPubMedCentral Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):659–69.CrossRefPubMedPubMedCentral
13.
go back to reference Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening, incidence, and mortality–United States, 2002–2010. MMWR Morb Mortal Wkly Rep. 2011;60(26):884–9. Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening, incidence, and mortality–United States, 2002–2010. MMWR Morb Mortal Wkly Rep. 2011;60(26):884–9.
14.
go back to reference Schroy 3rd PC, Emmons KM, Peters E, Glick JT, Robinson PA, Lydotes MA, et al. Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial. Am J Prev Med. 2012;43(6):573–83.CrossRefPubMedPubMedCentral Schroy 3rd PC, Emmons KM, Peters E, Glick JT, Robinson PA, Lydotes MA, et al. Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial. Am J Prev Med. 2012;43(6):573–83.CrossRefPubMedPubMedCentral
15.
go back to reference Almog R, Ezra G, Lavi I, Rennert G, Hagoel L. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prev. 2008;17(5):430–7.CrossRefPubMed Almog R, Ezra G, Lavi I, Rennert G, Hagoel L. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prev. 2008;17(5):430–7.CrossRefPubMed
16.
go back to reference Katsumura Y, Yasunaga H, Imamura T, Ohe K, Oyama H. Relationship between risk information on total colonoscopy and patient preferences for colorectal cancer screening options: analysis using the analytic hierarchy process. BMC Health Serv Res. 2008;8:106. doi:10.1186/1472-6963-8-106.CrossRefPubMedPubMedCentral Katsumura Y, Yasunaga H, Imamura T, Ohe K, Oyama H. Relationship between risk information on total colonoscopy and patient preferences for colorectal cancer screening options: analysis using the analytic hierarchy process. BMC Health Serv Res. 2008;8:106. doi:10.1186/1472-6963-8-106.CrossRefPubMedPubMedCentral
17.
go back to reference Dolan JG. Patient priorities in colorectal cancer screening decisions. Health Expect. 2005;8(4):334–44.CrossRefPubMed Dolan JG. Patient priorities in colorectal cancer screening decisions. Health Expect. 2005;8(4):334–44.CrossRefPubMed
18.
go back to reference Dolan JG, Boohaker E, Allison J, Imperiale TF. Patients’ preferences and priorities regarding colorectal cancer screening. Med Decis Making. 2013;33(1):59–70.CrossRefPubMed Dolan JG, Boohaker E, Allison J, Imperiale TF. Patients’ preferences and priorities regarding colorectal cancer screening. Med Decis Making. 2013;33(1):59–70.CrossRefPubMed
19.
go back to reference Hummel JM, Steuten LG, Groothuis-Oudshoorn CJ, Mulder N, Ijzerman MJ. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis. Appl Health Econ Health Policy. 2013;11(5):499–507.CrossRefPubMed Hummel JM, Steuten LG, Groothuis-Oudshoorn CJ, Mulder N, Ijzerman MJ. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis. Appl Health Econ Health Policy. 2013;11(5):499–507.CrossRefPubMed
20.
go back to reference Saaty TL. A scaling method for priorities in hierarchical structures. J Math Psychol. 1977;15(3):234–81.CrossRef Saaty TL. A scaling method for priorities in hierarchical structures. J Math Psychol. 1977;15(3):234–81.CrossRef
21.
go back to reference Saaty TL. The analytic hierarchy process: planning, priority setting, resource allocation. New York: McGraw; 1980. Saaty TL. The analytic hierarchy process: planning, priority setting, resource allocation. New York: McGraw; 1980.
22.
go back to reference Sato Y. Comparison between multiple-choice and analytic hierarchy process: measuring human perception. Int Trans Oper Res. 2004;11(1):77–86.CrossRef Sato Y. Comparison between multiple-choice and analytic hierarchy process: measuring human perception. Int Trans Oper Res. 2004;11(1):77–86.CrossRef
23.
go back to reference Forman E, Peniwati K. Aggregating individual judgments and priorities with the Analytic Hierarchy Process. Eur J Oper Res. 1998;108(1):165–9.CrossRef Forman E, Peniwati K. Aggregating individual judgments and priorities with the Analytic Hierarchy Process. Eur J Oper Res. 1998;108(1):165–9.CrossRef
24.
go back to reference Jones RM, Vernon SW, Woolf SH. Is discussion of colorectal cancer screening options associated with heightened patient confusion? Cancer Epidemiol Biomarkers Prev. 2010;19(11):2821–5.CrossRefPubMedPubMedCentral Jones RM, Vernon SW, Woolf SH. Is discussion of colorectal cancer screening options associated with heightened patient confusion? Cancer Epidemiol Biomarkers Prev. 2010;19(11):2821–5.CrossRefPubMedPubMedCentral
25.
go back to reference Whitaker R. Validation examples of the Analytic Hierarchy Process and Analytic Network Process. Math Comput Model. 2007;46(7–8):840–59.CrossRef Whitaker R. Validation examples of the Analytic Hierarchy Process and Analytic Network Process. Math Comput Model. 2007;46(7–8):840–59.CrossRef
26.
27.
go back to reference DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2008;23(2):169–74.CrossRefPubMed DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2008;23(2):169–74.CrossRefPubMed
28.
go back to reference Hawley ST, Volk RJ, Krishnamurthy P, Jibaja-Weiss M, Vernon SW, Kneuper S. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care. 2008;46(9 Suppl 1):S10–6.CrossRefPubMed Hawley ST, Volk RJ, Krishnamurthy P, Jibaja-Weiss M, Vernon SW, Kneuper S. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care. 2008;46(9 Suppl 1):S10–6.CrossRefPubMed
29.
go back to reference Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract. 1997;45(3):211–8.PubMed Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract. 1997;45(3):211–8.PubMed
30.
go back to reference Powell AA, Burgess DJ, Vernon SW, Griffin JM, Grill JP, Noorbaloochi S, et al. Colorectal cancer screening mode preferences among US veterans. Prev Med. 2009;49(5):442–8.CrossRefPubMed Powell AA, Burgess DJ, Vernon SW, Griffin JM, Grill JP, Noorbaloochi S, et al. Colorectal cancer screening mode preferences among US veterans. Prev Med. 2009;49(5):442–8.CrossRefPubMed
31.
go back to reference Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172(7):575–82.CrossRefPubMedPubMedCentral Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172(7):575–82.CrossRefPubMedPubMedCentral
32.
go back to reference Schwartz B. The paradox of choice: why less is more. New York: Ecco; 2004. Schwartz B. The paradox of choice: why less is more. New York: Ecco; 2004.
33.
go back to reference Grazzini G, Ventura L, Zappa M, Ciatto S, Confortini M, Rapi S, et al. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district. Gut. 2010;59(11):1511–5.CrossRefPubMed Grazzini G, Ventura L, Zappa M, Ciatto S, Confortini M, Rapi S, et al. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district. Gut. 2010;59(11):1511–5.CrossRefPubMed
34.
go back to reference Deutekom M, van Rijn AF, Dekker E, Blaauwgeers H, Stronks K, Fockens P, et al. Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands. Eur J Public Health. 2009;19(4):400–2.CrossRefPubMed Deutekom M, van Rijn AF, Dekker E, Blaauwgeers H, Stronks K, Fockens P, et al. Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands. Eur J Public Health. 2009;19(4):400–2.CrossRefPubMed
35.
go back to reference Halloran SP, Launoy G, Zappa M, International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Faecal occult blood testing. Endoscopy. 2012;44 Suppl 3:SE65–87.PubMed Halloran SP, Launoy G, Zappa M, International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Faecal occult blood testing. Endoscopy. 2012;44 Suppl 3:SE65–87.PubMed
36.
go back to reference Young GP. Population-based screening for colorectal cancer: Australian research and implementation. J Gastroenterol Hepatol. 2009;24 Suppl 3:S33–42.CrossRefPubMed Young GP. Population-based screening for colorectal cancer: Australian research and implementation. J Gastroenterol Hepatol. 2009;24 Suppl 3:S33–42.CrossRefPubMed
37.
go back to reference Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health. 2007;10(5):415–30.CrossRefPubMed Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health. 2007;10(5):415–30.CrossRefPubMed
38.
go back to reference Shokar NK, Carlson CA, Weller SC. Informed decision making changes test preferences for colorectal cancer screening in a diverse population. Ann Fam Med. 2010;8(2):141–50.CrossRefPubMedPubMedCentral Shokar NK, Carlson CA, Weller SC. Informed decision making changes test preferences for colorectal cancer screening in a diverse population. Ann Fam Med. 2010;8(2):141–50.CrossRefPubMedPubMedCentral
39.
go back to reference Griffith JM, Lewis CL, Brenner AR, Pignone MP. The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial. BMC Med Inform Decis Mak. 2008;8:4-6947-8-4. Griffith JM, Lewis CL, Brenner AR, Pignone MP. The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial. BMC Med Inform Decis Mak. 2008;8:4-6947-8-4.
Metadata
Title
Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process
Authors
Yinghui Xu
Barcey T Levy
Jeanette M Daly
George R Bergus
Jeffrey C Dunkelberg
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2015
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-015-0841-0

Other articles of this Issue 1/2015

BMC Health Services Research 1/2015 Go to the issue